Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Revenue (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Revenue readings, the most recent being $901000.0 for Q4 2025.

  • On a quarterly basis, Revenue fell 25.9% to $901000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 million, a 3.73% decrease, with the full-year FY2025 number at $4.9 million, down 3.71% from a year prior.
  • Revenue hit $901000.0 in Q4 2025 for Arcadia Biosciences, down from $1.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $837.0 million in Q2 2021 to a low of -$5.8 million in Q4 2022.
  • Median Revenue over the past 5 years was $1.3 million (2023), compared with a mean of $43.1 million.
  • Biggest five-year swings in Revenue: skyrocketed 297764.77% in 2021 and later crashed 235.16% in 2022.
  • Arcadia Biosciences' Revenue stood at $4.3 million in 2021, then crashed by 235.16% to -$5.8 million in 2022, then soared by 113.37% to $777000.0 in 2023, then soared by 56.5% to $1.2 million in 2024, then dropped by 25.9% to $901000.0 in 2025.
  • The last three reported values for Revenue were $901000.0 (Q4 2025), $1.3 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.